↓ Skip to main content

Inclisiran: a new generation of lipid-lowering siRNA therapeutic

Overview of attention for article published in Frontiers in Pharmacology, October 2023
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age and source (68th percentile)

Mentioned by

twitter
2 X users

Readers on

mendeley
27 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Inclisiran: a new generation of lipid-lowering siRNA therapeutic
Published in
Frontiers in Pharmacology, October 2023
DOI 10.3389/fphar.2023.1260921
Pubmed ID
Authors

Yanzhen Zhang, Huaigang Chen, Lang Hong, Hong Wang, Bin Li, Mengyin Zhang, Jiamei Li, Liu Yang, Fan Liu

Timeline

Login to access the full chart related to this output.

If you don’t have an account, click here to discover Explorer

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 27 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 27 100%

Demographic breakdown

Readers by professional status Count As %
Unspecified 3 11%
Professor 2 7%
Student > Bachelor 1 4%
Researcher 1 4%
Other 1 4%
Other 0 0%
Unknown 19 70%
Readers by discipline Count As %
Unspecified 3 11%
Medicine and Dentistry 3 11%
Biochemistry, Genetics and Molecular Biology 2 7%
Unknown 19 70%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 July 2024.
All research outputs
#20,809,834
of 26,436,676 outputs
Outputs from Frontiers in Pharmacology
#8,848
of 20,489 outputs
Outputs of similar age
#250,517
of 369,734 outputs
Outputs of similar age from Frontiers in Pharmacology
#180
of 700 outputs
Altmetric has tracked 26,436,676 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 20,489 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.4. This one is in the 49th percentile – i.e., 49% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 369,734 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 28th percentile – i.e., 28% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 700 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 68% of its contemporaries.